Opinion 7 Jul 2021 Three Lessons an Investor Can Learn from Biotech Entrepreneurs …building startups. Who else but someone who marches to the beat of their own drum would have the audacity to look at a problem that thousands might have already examined… July 7, 2021 - 7 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Apr 2023 5 biotech companies to discover in Bangalore …technology platforms to conduct their research, and help startups by giving them access to facilities and mentors they might otherwise struggle to find. Not only has this made Bangalore the… April 24, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2021 Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer …targets include a €10M seed round raised last year by the Swiss startup FoRx Therapeutics along with big pharma collaborations in North America including Bristol Myers Squibb with the Canadian… August 6, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 22 Aug 2023 Lab-grown babies on the horizon: how IVG could transform human reproduction …to reproduce naturally, including for same-sex couples. California startup’s ambitious plan to make lab-grown babies The research by Japanese scientists surrounding IVG has now led to a crop of biotech… August 22, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2025 Top biotech deals in June 2025 …of May. While many seasoned players, such as Sanofi, Lilly, Novartis, and Novo Nordisk took part in M&As and licensing deals, new biotechs and startups also entered the scene. With… July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jan 2022 Norwegian Biotech Put on the Map with €18M Oncology Round The immuno-oncology startup Cytovation has raised €17.7M (NOK 180M) in one of Norway’s biggest Series A rounds in life sciences. Historically, Norway’s biotech scene has not seen the kind of… January 26, 2022 - 3 minutesmins - By Dan Samorodnitsky Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2023 The promise of immunotherapy for autoimmune diseases …Startups aim for autoimmune therapy breakthroughs As CAR-T therapy has been hailed as a win for lupus research, breakthroughs in multiple sclerosis and ulcerative colitis treatment are much awaited. Various… June 27, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 13 Oct 2021 Thinking About Risk Early on Is Key for Cell Therapy Success …therapies do go through a rigorous development process, it is still a relatively new field. Risk management and quality control can be difficult to navigate for new startups looking to… October 13, 2021 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2022 Biotechs Carve out Niches in Cystic Fibrosis Treatment Space …mutations. Enter Italian startup Kither Biotech, which raised €18.5M in a Series B financing last week. Kither’s first-in-class inhaled peptide is designed to enhance existing cystic fibrosis treatments by acting… March 22, 2022 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2022 EU Bioeconomy Fund Bags €300M to Scale up Sustainability Companies …of funding for startups to scale up their technology. According to Michael Brandkamp, co-founder and Managing Partner of the sustainability-focused European Circular Bioeconomy Fund (ECBF), this lack of funding is… February 23, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 27 Sep 2017 How to Survive the Valley of Death: Tips from Europe’s Largest Research Hospital Taking research from the bench to the bedside is an infamous graveyard in biotech. Researchers from Charité and their colleagues have a plan to help startups survive. “Many basic research… September 27, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 28 Jun 2024 Going nuclear: radiopharmaceuticals funding sees surge in 2024 …industry, RayzeBio. The California-based startup’s lead candidate RYZ101 is currently in phase 3 clinical trials for patients with neuroendocrine tumors, which is poised to be the first actinium-225 (Ac225) approved… June 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email